Identification de Marqueurs de Mauvais Pronostic Clinique du Sepsis Par Analyse épigénétique.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Sepsis is a multifactorial syndrome characterized by a dynamic course and a clinical outcome dependent on several factors, and responsible for one in five deaths worldwide. The aim of this trial is to identify new prognostic markers for the progression of sepsis to septic shock, by comparing epigenetic markers between patients who have or have not developed severe forms of sepsis. The main objective of this preliminary study is to identify prognostic markers for the progression of sepsis to septic shock, i.e. to compare targeted markers between subjects with sepsis who progress to septic shock versus subjects with sepsis who do not progress to septic shock.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 45
Maximum Age: 75
Healthy Volunteers: f
View:

• Male patients,

• Patients between 45 and 75 years of age,

• Patients undergoing major esophageal or digestive carcinological surgery,

• Patients with post-operative gram-negative bacterial sepsis (proven or suspected in the context of organ failure).

Locations
Other Locations
France
Service Anesthésie Réanimation - Hôpital Nord - Assistance Publique Hôpitaux de Marseille
RECRUITING
Marseille
Contact Information
Primary
Marc LEONE, MD PHD
marc.leone@ap-hm.fr
0491968655
Time Frame
Start Date: 2025-03-20
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 25
Treatments
Septic shock
Patients with sepsis admitted to intensive care who developed septic shock.
No septic shock
Patients with sepsis admitted to critical care with a favorable outcome (no septic shock)
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique Hopitaux De Marseille

This content was sourced from clinicaltrials.gov